Jupiter Neurosciences, Inc. $JUNS Stock Sold by Vestor Capital LLC

Vestor Capital LLC reduced its holdings in shares of Jupiter Neurosciences, Inc. (NASDAQ:JUNS) by 98.6% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 14,009 shares of the company’s stock after selling 959,169 shares during the period. Vestor Capital LLC’s holdings in Jupiter Neurosciences were worth $34,000 at the end of the most recent quarter.

Jupiter Neurosciences Stock Up 0.9%

Shares of NASDAQ JUNS opened at $2.22 on Wednesday. Jupiter Neurosciences, Inc. has a 1-year low of $2.01 and a 1-year high of $103.50. The business has a 50-day moving average of $2.79 and a 200-day moving average of $18.87.

Jupiter Neurosciences (NASDAQ:JUNS) last announced its earnings results on Friday, August 14th. The company reported ($5.06) EPS for the quarter, missing the consensus estimate of ($3.75) by ($1.31). The company had revenue of $0.02 million during the quarter, compared to analyst estimates of $0.40 million.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of Jupiter Neurosciences from a “strong sell” rating to a “sell” rating in a research report on Sunday, August 16th. Weiss Ratings restated a “sell (e+)” rating on shares of Jupiter Neurosciences in a report on Monday, September 21st. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Jupiter Neurosciences presently has an average rating of “Sell”.

Jupiter Neurosciences Company Profile

Jupiter Neurosciences, Inc. (NASDAQ:JUNS) is a clinical-stage biotechnology company focused on developing therapies for diseases associated with neuroinflammation. The company’s research is centered on small-molecule drug candidates intended to address inflammatory processes affecting the central nervous system. Jupiter Neurosciences’ lead product candidate, JNS-101, is an orally administered, brain-penetrant compound being developed for its potential anti-inflammatory and neuroprotective effects.